Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,545.5
-13.6 (-0.53%)

 

  • STI Straits Times Index
    2,545.5
    -13.6 (-0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,578.1
    -10.4 (-0.66%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,531.6
    -399.0 (-1.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,354.0
    -32.4 (-0.96%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,329.9
    -88.2 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,143.9
    -34.4 (-0.66%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,268.2M
  • Value: 1,358.8M
  • Rise: 113
  • Fall: 217
  • Unch: 478

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008+0.001
ThaiBev0.605-0.020
Genting Sing0.680-0.030
Asian Healthcare0.285+0.050
Vicplas Intl0.390+0.065
ISDN0.395+0.030
AsiaMedic0.023+0.002
CNMC Goldmine0.360+0.015
Rex Intl0.184-0.003
Medtecs Intl0.970-0.030

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VOYAGER THERAPEUTICS INC VOYAGER THERAPEUTICS
Updated on 07 Aug 2020 (End of trading day)
Last (USD): 11.190 Change: +0.200 High: 11.340 Remarks: -
Change (%): +1.82 Low: 10.790
Open 10.900 Yesterday's Close 10.99
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 212,092 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.17226 Trailing EPS (USD) e -1.09412 NAV (USD) b 2.1445
PE a - Trailing PE f - Price / NAV b 5.2180
Dividend (USD) d - Cash In Hand (USD) g 4.4427 Issued & Paid-up Shares c 37,190,700
Dividend Yield (%) d - Price / Cash In Hand g 2.519 Treasury Shares h -
Market Cap (M) 416.164 Enterprise Value (M) 198.627
Piotroski F Score 3 Exchange Code VYGR Par Value ( $ ) n.a.
52 Weeks Volatility (%) 72.75 Free Float (%) 64.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 18 Jun 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 09 Nov 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VOYAGER THERAPEUTICS INC NASDAQ 416.164 - - 5.2180 -
Industry Biotechnology NASDAQ 2,892.875 415.454 6455.431 7.6765 0.647
Local Peer AMGEN INC NASDAQ 140,970.689 17.976 19.314 13.2255 2.433
Local Peer GILEAD SCIENCES INC NASDAQ 86,945.482 16.143 - 4.8231 3.669
Local Peer VERTEX PHARMACEUTICAL NASDAQ 71,104.886 60.422 34.172 9.4564 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 65,985.364 31.187 22.117 7.2852 -
Local Peer ILLUMINA INC NASDAQ 52,282.020 52.178 80.932 - -
Local Peer BIOGEN INC NASDAQ 48,397.867 8.219 8.166 4.2797 -
Local Peer MODERNA INC NASDAQ 28,811.858 - - 9.7770 -
Local Peer SEATTLE GENETICS INC NASDAQ 27,917.819 - - 15.3896 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,636.187 9.415 26.754 2.1577 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 21,520.804 - 176.028 6.6490 -
Local Peer INCYTE CORPORATION NASDAQ 21,198.494 47.434 - 9.0414 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 19,849.212 - - 7.0583 -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NOVAVAX INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), FATE THERAPEUTICS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), XENCOR INC (NASDAQ), UNIQURE N.V. (NASDAQ), VERACYTE INC (NASDAQ), VAXCYTE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MACROGENICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), EPIZYME INC (NASDAQ), CORTEXYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), ARVINAS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), RETROPHIN INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), NKARTA INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PASSAGE BIO INC (NASDAQ), OMEROS CORP (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), PERSONALIS INC (NASDAQ), AKOUOS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AGENUS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), GERON CORP (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ATHERSYS INC (NASDAQ), ARDELYX INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), ANAPTYSBIO INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), MERUS B V (NASDAQ), IVERIC BIO INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), IMV INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AFFIMED N V (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MEDICINOVA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), NEXTCURE INC (NASDAQ), CHIASMA INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), TREVENA INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), VERASTEM INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), CHIMERIX INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), XOMA CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), EQUILLIUM INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), INMUNE BIO INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), LUMOS PHARMA INC (NASDAQ), ORGENESIS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), SESEN BIO INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), RECRO PHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ARAVIVE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), RESTORBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), COHBAR INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SOLIGENIX INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ADVAXIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), BIOCARDIA INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer CSL ASX 124,495.695 46.403 42.977 14.3952 0.967
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer WUXI BIO HKEx 228,464.733 198.740 198.739 15.9759 -
Global Peer SINO BIOPHARM HKEx 183,064.220 59.645 60.190 5.2838 0.548
Global Peer BEIGENE HKEx 156,345.400 - - - -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 6,915.167 126.884 40.606 5.7684 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 31,551.186 - - 10.5778 -
Global Peer 3SBIO HKEx 23,375.225 21.171 21.171 2.1711 -
Global Peer HAOHAI BIOTEC HKEx 21,606.322 51.391 51.391 3.6734 0.631
Other Global Peers VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), ASCENTAGE-B (HKEx), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), DPHARMA (Bursa), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), IBIO INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TELIX PHARMACEUTIC (ASX), PFENEX INC (NYSE American), IMUGENE LIMITED (ASX), NEXT SCIENCE LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ANTEOTECH LIMITED (ASX), MEMPHASYS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), IMMUTEP LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), GENETIC TECHNOLOGIES (ASX), BIOTRON (ASX), ORAGENICS INC (NYSE American), CT ENTERPRISE (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), BIONOMICS LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), BIOSINO BIO-TEC (HKEx), CONSTELLATION TECHNOLOGIES LTD (ASX), Suntar Eco-City (SGX), REGENEUS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), HAO WEN H-NEW (HKEx), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), HAO WEN H-OLD (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.120
+1.08 %
10 Days --0.860
-7.14 %
20 Days --1.720
-13.32 %
Medium Term Return 3 Months -+0.040
+0.36 %
6 Months --1.770
-13.66 %
1 Year --9.340
-45.49 %
Long Term Return 2 Years --6.970
-38.38 %
3 Years -+2.460
+28.18 %
Annualised Return Annualised --
+8.63 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.260 - 23.500 Change From 1 Year Low +4.930 % Change From 1 Year Low (%) +78.75
Change From 1 Year High -12.310 % Change From 1 Year High (%) -52.38
2 Years Range 6.260 - 28.790 Change From 2 Years Low +4.930 % Change From 2 Years Low (%) +78.75
Change From 2 Years High -17.600 % Change From 2 Years High (%) -61.13
5 Years Range 6.260 - 31.910 Change From 5 Years Low +4.930 % Change From 5 Years Low (%) +78.75
Change From 5 Years High -20.720 % Change From 5 Years High (%) -64.93
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guangping Gao, Mark A. Kay, Krystof Bankiewicz and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
07 Aug 2020 10.900 11.340 10.790 11.190 212,092 -
06 Aug 2020 10.800 11.160 10.450 10.990 237,615 -
05 Aug 2020 10.450 10.810 10.340 10.810 356,024 -
04 Aug 2020 10.830 10.880 9.844 10.350 472,889 -
03 Aug 2020 11.140 11.400 11.025 11.330 215,899 -
31 Jul 2020 11.430 11.430 10.870 11.070 237,966 -
30 Jul 2020 11.200 11.710 11.170 11.450 148,798 -
29 Jul 2020 11.800 11.880 11.230 11.340 291,210 -
28 Jul 2020 12.190 12.376 11.770 11.800 154,816 -
27 Jul 2020 12.040 12.390 12.040 12.250 174,320 -
24 Jul 2020 12.470 12.700 11.990 12.050 171,146 -
23 Jul 2020 12.540 12.670 12.060 12.520 220,105 -
22 Jul 2020 12.550 12.760 12.450 12.540 158,558 -
21 Jul 2020 13.100 13.107 12.560 12.640 237,540 -
20 Jul 2020 13.070 13.420 12.870 13.010 164,392 -
17 Jul 2020 13.040 13.500 12.910 12.980 238,112 -
16 Jul 2020 13.570 13.570 12.495 12.920 614,068 -
15 Jul 2020 13.210 13.990 13.210 13.750 594,445 -
14 Jul 2020 12.330 12.820 12.040 12.820 585,234 -
13 Jul 2020 13.020 13.200 12.360 12.410 594,953 -
10 Jul 2020 13.310 13.540 12.680 12.910 316,454 -
09 Jul 2020 13.630 13.780 13.100 13.330 293,145 -
Summary
Current 2 Weeks
(27 Jul 2020 to 07 Aug 2020)
12.040 12.390 9.844 11.190 2,501,629 -
Previous 2 Weeks
(13 Jul 2020 to 24 Jul 2020)
13.020 13.200 9.844 12.050 3,578,553 -
4 Weeks from
(12 Jun 2020 to 10 Jul 2020)
12.480 12.735 9.844 12.910 6,071,029 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.